Notice: Undefined property: WP_Error::$slug in /var/www/medicalconferences/wp-content/themes/writers-blogily-new/category.php on line 41

Online First

EHA 2024

ASH 2023

EHA 2023

EBMT 2023

ASH 2022

EHA 2022

ASH 2021 Focus on CAR T-Cell Therapy

ASH 2021

EHA 2021

Immune therapy of multiple myeloma

Presented By
Prof. Noopur Raje, Massachusetts General Cancer Center, USA
Trial
KarMMA; CARTITUDE-1; UNIVERSAL
Conference
EHA 2021
Type
Peer-reviewed article

ASH 2020

MPN disease burden, quality of life, and treatment patterns

Presented By
Dr Rami S. Komrokji (H. Lee Moffitt Cancer Center and Research Institute, Florida, USA) & Dr Michael R. Grunwald (Levine Cancer Institute, North Carolina, USA)
Trial
MOST
Conference
ASH 2020
Type
Peer-reviewed article

New insights into genetics of MPN

Presented By
Dr Jyoti Nangalia, University of Cambridge, United Kingdom
Conference
ASH 2020
Type
Peer-reviewed article

EHA 2020

OS benefit in VIALE-C trial

Presented By
Prof. Andrew Wei, Monash University, Australia
Trial
Phase 3, VIALE-C
Conference
EHA 2020
Type
Peer-reviewed article

Two trials: acalabrutinib in CLL

Presented By
Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA
Trial
Phase 2, ACE-CL-001, ASCEND
Conference
EHA 2020
Type
Peer-reviewed article

Daratumumab for light-chain amyloidosis

Presented By
Dr Efstathios Kastritis, National and Kapodistrian University of Athens, Greece
Trial
Phase 3, ANDROMEDA
Conference
EHA 2020
Type
Peer-reviewed article

Microbiome predicts B-ALL predisposition

Presented By
Dr Carolina Vincente-Dueñas, Institute of Biomedical Research of Salamanca, Spain
Conference
EHA 2020
Type
Peer-reviewed article

ASH 2019

EHA 2019

ASH 2018

EHA 2018

EHA 2017